These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28838033)

  • 1. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
    Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
    Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
    Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
    Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
    Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
    Moik F; Riedl JM; Winder T; Terbuch A; Rossmann CH; Szkandera J; Bauernhofer T; Kasparek AK; Schaberl-Moser R; Reicher A; Prinz F; Pichler M; Stöger H; Stotz M; Gerger A; Posch F
    Sci Rep; 2019 Apr; 9(1):5548. PubMed ID: 30944390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study.
    Hirao T; Ikezawa K; Morishima T; Daiku K; Seiki Y; Watsuji K; Kawamoto Y; Higashi S; Urabe M; Kai Y; Takada R; Yamai T; Mukai K; Nakabori T; Uehara H; Miyashiro I; Ohkawa K
    BMC Gastroenterol; 2023 Aug; 23(1):263. PubMed ID: 37528334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy and Outcomes in Older Adult Patients With Biliary Tract Cancer.
    Gbolahan OB; Zhi X; Liu Y; Shah MM; Kooby DA; Alese OB
    JAMA Netw Open; 2024 Jan; 7(1):e2351502. PubMed ID: 38206623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older adults with biliary tract cancer: treatment and prognosis.
    Lee BS; Hwang JH; Lee SH; Jang SE; Ahn DW; Hwang DW; Cho JY; Yoon YS; Han HS; Ahn S
    J Am Geriatr Soc; 2012 Oct; 60(10):1862-71. PubMed ID: 23035728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancer: A STROBE-compliant retrospective cohort study.
    Yin L; Xu Q; Li J; Wei Q; Ying J
    Medicine (Baltimore); 2018 Dec; 97(50):e13570. PubMed ID: 30558021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
    Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
    Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.
    Murakawa Y; Sakayori M; Otsuka K
    BMC Palliat Care; 2019 Jun; 18(1):45. PubMed ID: 31159782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
    Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
    BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.
    Iwaku A; Kinoshita A; Onoda H; Fushiya N; Nishino H; Matsushima M; Tajiri H
    Med Oncol; 2014 Jan; 31(1):787. PubMed ID: 24310810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy.
    Saisho T; Okusaka T; Ueno H; Morizane C; Okada S
    Hepatogastroenterology; 2005; 52(66):1654-8. PubMed ID: 16334750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.
    Kus T; Aktas G; Kalender ME; Sevinc A; Camci C
    J Gastrointest Cancer; 2017 Jun; 48(2):170-175. PubMed ID: 27714651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy.
    Lee DW; Im SA; Kim YJ; Yang Y; Rhee J; Na II; Lee KH; Kim TY; Han SW; Choi IS; Oh DY; Kim JH; Kim TY; Bang YJ
    Cancer Res Treat; 2017 Jul; 49(3):807-815. PubMed ID: 28111425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.
    Agarwal R; Sendilnathan A; Siddiqi NI; Gulati S; Ghose A; Xie C; Olowokure OO
    J Gastrointest Oncol; 2016 Dec; 7(6):996-1003. PubMed ID: 28078124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor Prognosis of Advanced Cholangiocarcinoma: Real-World Data from a Tertiary Referral Center.
    Koch C; Franzke C; Bechstein WO; Schnitzbauer AA; Filmann N; Vogl T; Gruber-Rouh T; Zeuzem S; Waidmann O; Trojan J
    Digestion; 2020; 101(4):458-465. PubMed ID: 31129660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.